These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 16968795)

  • 1. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.
    Daly AF; Rixhon M; Adam C; Dempegioti A; Tichomirowa MA; Beckers A
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4769-75. PubMed ID: 16968795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and characteristics of sellar masses in the city of Al Ain, United Arab Emirates: 2010 to 2016.
    Aldahmani KM; Sreedharan J; Ismail MM; Philip J; Nair SC; Alfelasi M; Aziz W; Imran SA; Alkaabi J
    Ann Saudi Med; 2020; 40(2):105-112. PubMed ID: 32241168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011.
    Tjörnstrand A; Gunnarsson K; Evert M; Holmberg E; Ragnarsson O; Rosén T; Filipsson Nyström H
    Eur J Endocrinol; 2014 Oct; 171(4):519-26. PubMed ID: 25084775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coping strategies in patients after treatment for functioning or nonfunctioning pituitary adenomas.
    Tiemensma J; Kaptein AA; Pereira AM; Smit JW; Romijn JA; Biermasz NR
    J Clin Endocrinol Metab; 2011 Apr; 96(4):964-71. PubMed ID: 21209028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study.
    Agustsson TT; Baldvinsdottir T; Jonasson JG; Olafsdottir E; Steinthorsdottir V; Sigurdsson G; Thorsson AV; Carroll PV; Korbonits M; Benediktsson R
    Eur J Endocrinol; 2015 Nov; 173(5):655-64. PubMed ID: 26423473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characterization of familial isolated pituitary adenomas.
    Daly AF; Jaffrain-Rea ML; Ciccarelli A; Valdes-Socin H; Rohmer V; Tamburrano G; Borson-Chazot C; Estour B; Ciccarelli E; Brue T; Ferolla P; Emy P; Colao A; De Menis E; Lecomte P; Penfornis F; Delemer B; Bertherat J; Wémeau JL; De Herder W; Archambeaud F; Stevenaert A; Calender A; Murat A; Cavagnini F; Beckers A
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3316-23. PubMed ID: 16787992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Epidemiology of Pituitary Adenomas.
    Daly AF; Beckers A
    Endocrinol Metab Clin North Am; 2020 Sep; 49(3):347-355. PubMed ID: 32741475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: Pituitary adenomas in children and adolescents.
    Katavetin P; Cheunsuchon P; Swearingen B; Hedley-Whyte ET; Misra M; Levitsky LL
    J Pediatr Endocrinol Metab; 2010 May; 23(5):427-31. PubMed ID: 20662340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic transsphenoidal treatment of hormonally active pituitary adenomas.
    Rudnik A; Kos-Kudła B; Larysz D; Zawadzki T; Bazowski P
    Neuro Endocrinol Lett; 2007 Aug; 28(4):438-44. PubMed ID: 17693972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.
    Vergès B; Boureille F; Goudet P; Murat A; Beckers A; Sassolas G; Cougard P; Chambe B; Montvernay C; Calender A
    J Clin Endocrinol Metab; 2002 Feb; 87(2):457-65. PubMed ID: 11836268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
    Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric pituitary adenoma: a series of 42 patients.
    Pandey P; Ojha BK; Mahapatra AK
    J Clin Neurosci; 2005 Feb; 12(2):124-7. PubMed ID: 15749410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and endocrine aspects of pituitary tumors.
    Zargar AH; Laway BA; Masoodi SR; Salahuddin M; Ganie MA; Bhat MH; Wani AI; Bashir MI
    Saudi Med J; 2004 Oct; 25(10):1428-32. PubMed ID: 15494816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina.
    Day PF; Loto MG; Glerean M; Picasso MF; Lovazzano S; Giunta DH
    Arch Endocrinol Metab; 2016; 60(6):554-561. PubMed ID: 27982201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of familial pituitary adenoma syndromes among patients with functioning pituitary adenomas in a reference outpatient clinic.
    Marques NV; Kasuki L; Coelho MC; Lima CHA; Wildemberg LE; Gadelha MR
    J Endocrinol Invest; 2017 Dec; 40(12):1381-1387. PubMed ID: 28689311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China.
    Wu Y; Gao L; Guo X; Wang Z; Lian W; Deng K; Lu L; Xing B; Zhu H
    Pituitary; 2019 Apr; 22(2):113-123. PubMed ID: 30637623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
    Lambert K; Rees K; Seed PT; Dhanjal MK; Knight M; McCance DR; Williamson C
    Obstet Gynecol; 2017 Jan; 129(1):185-194. PubMed ID: 27926659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden.
    Ónnestam L; Berinder K; Burman P; Dahlqvist P; Engström BE; Wahlberg J; Nyström HF
    J Clin Endocrinol Metab; 2013 Feb; 98(2):626-35. PubMed ID: 23295463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study.
    Daly AF; Tichomirowa MA; Petrossians P; Heliövaara E; Jaffrain-Rea ML; Barlier A; Naves LA; Ebeling T; Karhu A; Raappana A; Cazabat L; De Menis E; Montañana CF; Raverot G; Weil RJ; Sane T; Maiter D; Neggers S; Yaneva M; Tabarin A; Verrua E; Eloranta E; Murat A; Vierimaa O; Salmela PI; Emy P; Toledo RA; Sabaté MI; Villa C; Popelier M; Salvatori R; Jennings J; Longás AF; Labarta Aizpún JI; Georgitsi M; Paschke R; Ronchi C; Valimaki M; Saloranta C; De Herder W; Cozzi R; Guitelman M; Magri F; Lagonigro MS; Halaby G; Corman V; Hagelstein MT; Vanbellinghen JF; Barra GB; Gimenez-Roqueplo AP; Cameron FJ; Borson-Chazot F; Holdaway I; Toledo SP; Stalla GK; Spada A; Zacharieva S; Bertherat J; Brue T; Bours V; Chanson P; Aaltonen LA; Beckers A
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E373-83. PubMed ID: 20685857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma.
    Dekkers OM; Biermasz NR; Pereira AM; Roelfsema F; van Aken MO; Voormolen JH; Romijn JA
    J Clin Endocrinol Metab; 2007 Mar; 92(3):976-81. PubMed ID: 17200171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.